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Type 2 diabetes and essential hypertension are both very common chronic diseases. Type 2 
diabetes is often associated with hypertension, but the exact causes of them are unknown. 
Here, based on recent investigations, we will look at the pathogenesis of these two diseases in 
a new light. 
 
Nowadays, the number of people diagnosed as type 2 diabetes has been over 150 million 
worldwide1, and that of essential hypertension is about 1 billion2, regardless of patients 
undiagnosed. Although having been researched for decades, the pathogenesis is not fully 
understood. The predominant theories consider type 2 diabetes as a metabolic disorder, which is 
characterized by insulin resistance. Insulin resistance can progress to type 2 diabetes, but its cause 
is now obscure, which may be food, genetic factors and some states of disease. If the pancreatic 
beta-cells cannot produce sufficient insulin in a condition of hyperglycaemia, insulin resistance 
has transited to type 2 diabetes3. Interestingly, even in the absence of hyperglycaemia, insulin 
resistance is correlated with obesity4 and hypertension5. Some researches suggested that type 2 
diabetes is a risk factor for hypertension6, some others argued that insulin resistance and obesity 
might be the catalyst for each other7, and a prevailing view considers obesity as a risk factor for 
both type 2 diabetes (or frank insulin resistance) and essential hypertension8。An obvious question 
is posed: obesity and type 2 diabetes, who is the egg and who is the hen? Just recently, O’Rahilly 
reviewed the genetic researches on type 2 diabetes and obesity, and suggested that intrinsic 
biological but not environmental factors have a major role9. Although several genes have been 
targeted, the fundamental etiological factor of these two diseases has not been illuminated. We 
should notice that the managements for type 2 diabetes are now to aim directly at regulating blood 
glucose or blood pressure. Patients tried their best to avoid aggravation, but most of them still 
suffered severely from the disease especially when they get old. Therefore, the crucial biological 
factor deciding the onset of this disease has not been discovered. The same circumstances also 
exist in the research and therapy for essential hypertension10. A theory approved by many 
researchers relates the renin - angiotensin system to the pathogenesis of hypertension11,12, but 
some hypertensive patients having low renin levels and the failure of therapy make this theory 
imperfect. In our opinion, type 2 diabetes and essential hypertension may share a common 
biological origin: neuron impairment or loss in brain. There have been documents raising the new 
point that the central nervous system should be the therapeutic target for type 2 diabetes or 
hypertension13,14,15,16,17. Our viewpoint is more radical, and we deem that the knowledge of type 2 
diabetes and essential hypertension should be re-organized in order to improve the diagnosis and 
therapy. Before explaining our viewpoint, let’s inspect the similarities of these two diseases. 
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Similarities between type 2 diabetes and essential hypertension on risk factors   
Some similarities on risk factors should be mentioned here for a better explanation later. (1) 
Obesity is found in at least 80% of patients diagnosed with type 2 diabetes4, and for essential 
hypertension, the percentage is about 85%18. Now, obesity is regarded as a risk factor for both of 
these two diseases. (2) Chronic stress, which is related with high levels of corticosteroid19, 
facilitates the pathogenesis of both diseases. In China, most patients diagnosed with type 2 
diabetes and essential hypertension in 1990’s are those engaged in job of high stress, for example, 
the executive of a large company. Nowadays, more and more city dwellers in China are affected 
by these diseases. Evidence suggested that high levels of corticosteroid will damage neurons in 
brain20. Sub-clinical Cushing’s syndrome, which characterizes as cortisol excess, is also associated 
with type 2 diabetes and hypertension21. (3) Diets that are high in fatty acid increase the risk of 
insulin resistance and essential hypertension. Traditional viewpoints focused mainly on disorders 
of fat cell metabolism and the reduced compliance of blood vessels respectively. (4) Sympathetic 
nervous system activation exists in both diseases7, and sympathetic excitation caused by sleep 
apnea increases corticotropin releasing hormone, cortisol production and inflammatory cytokines22 
which correlate with stress and fatigue. (5) Cigarette smoking is a known factor for the 
development of both diseases. (6) Both diseases are age related23. (7) Both diseases are heritable 
and may caused by more than one gene9,24. Although there are so many similarities on risk factors, 
researches on pathogenesis of type 2 diabetes and essential hypertension are separate from each 
other till now. We think that explaining the pathogenesis of these two diseases by a single reason 
may be more harmonized with the circumstances. 
 
Neuron impairment or loss in brain may be the primary pathological change   
In our point of view, type 2 diabetes and essential hypertension are not just diseases of endocrine 
system and cardiovascular system respectively, but may substantially be a disease of central 
nervous system. Stress or other environmental factors make some neurons in brain unhealthy. And 
then, if the unhealthy stimuli persist and accumulate, neurons may die and be eliminated. This 
kind of neuron loss may happens firstly and mainly at solitary nucleus in brain stem, or amygdala 
in the limbic system for some unknown anatomical or physiological reasons. At the early stage, 
only a few neurons are impaired or lost, so the neurons alive can keep working as compensation. 
During this time, no clinical symptoms could be observed. If neurons continue to lose, the 
homeostasis will not be sustained, so the pathological changes get into infernal circle. From then 
on, several symptoms emerge. The neuron loss at solitary nucleus make the sympathetic system 
relatively predominate and overactive. Sympathetic excitation can raise the cardiac output. 
Simultaneously or at a later stage, it can also increase the total peripheral resistance. This may be 
the influence of neuron loss for cardiovascular system. On the other hand, sympathetic excitation 
increases adrenaline levels, which stimulate the release of corticosteroid, and then increases stress 
responses. So the insulin resistance is a result of persistent sympathetic excitation, but not just the 
metabolic disorders of fat cells, skeletal muscle cells or liver cells. Insulin resistance leads to 
raised pancreatic beta cell secreting, which may be exhausted, and the blood glucose will 
ultimately go out of control. This is our explanation of the pathogenesis of type 2 diabetes. The 



































Discussion about neuron impairment or loss at solitary nucleus or amygdala 
Why is solitary nucleus or amygdala the suspected region of neuron impairment or loss? 
Documents of Researches on neuroanatomy and neurophysiology which are not new give us the 
clue. Solitary nucleus is a centre of parasympathetic system. There are glucose sensitive neurons 
at solitary nucleus which transmit satiate information to hypothalamus25. The glucagons-like 
peptidergic neurons at solitary nucleus are one of the target for leptin26, which reduces food intake 
and lowers the body weight27. Solitary nucleus locates at the crossroad of nerve tract related to 
cognitive and autonomic modulation28, and is vulnerable to reactive oxygen29. Furthermore, most 
neurons at solitary nucleus express glutamate receptor30, and are innervated by excitatory afferent 
fibres31, so they may be vulnerable to excitotoxicity32. An important gamma-aminobutyric acid 
(GABA) afference of solitary nucleus is from amygdala33, which play a pivotal role in emotion 
and stress integration34,28. This inhibitory projection can be regarded as a protector as well as 
suppression for the neurons at solitary nucleus. In the condition of chronic stress, hippocampus 
and amygdala will be influenced under the control of cerebral cortex20, and the solitary nucleus 
may be involved accordingly. The neuron impairment or loss at solitary nucleus will lead to 
attenuation of parasympathetic system and then the sympathetic system predominates. As the 
process of figure 1, persistent sympathetic excitation results in infernal circles. On the other hand, 
if the impairment takes place in neurons of amygdala (also because of chronic stress), the 
inhibitory projection to solitary nucleus is weakened, and the possibility of excitatory impairment 
for neurons at solitary nucleus will increase. So, neuron impairment or loss in either of solitary 
nucleus or amygdala can develop to the same outcome.  
 The schematic representation (Figure 2) of the role of solitary nucleus and amygdala in the 
nervous system may be helpful for comprehending their impairment in a view of evolution. 
Compared with other animals, the neocortex of human and some other higher mammals is 
extended greatly. The extended neocortex likes a new subassembly added to the old limbic system. 
It is this new subassembly that increases the pressure of the old autonomic nervous system. The 
complicated mental activity, which is related to the neocortex, may influence the autonomic 
nervous system through amygdala-solitary nucleus pathway. The vulnerability of this pathway 
may be a bottleneck of the brain evolution. 
 
How do risk factors correlate with neuron loss? 
We should now use the new viewpoint to re-inspect the risk factors for type 2 diabetes and 
essential hypertension.  
Stress and corticosteroid level. Nowadays, chronic stress is very common for city dwellers all 
over the world. Neuronal impairments made by chronic stress may be crucial for the pathogenesis 
of type 2 diabetes and essential hypertension. Animal experiments link the stress condition with 
high levels of corticosteroids19. Early experiment found that the hippocampal CA3 pyramidal 
neurons is lost during chronic glucocorticoid administration35. Some researchers did not find the 
evidence for neuron loss, but verified that the total volume of hippocampus is reduced36, and some 
neuronal processes are replaced by glial processes37. Rats receiving high doses of corticosterone 
for 3 weeks were found that their dendrites of layer II/III pyramidal neurons in the medial 
prefrontal cortex retracted compared to control animals38. These morphological evidences from 
hippocampus and cerebral cortex suggest that a high corticosteroid level is harmful for neurons in 


































central nervous system impairment caused by stress was reviewed by Arnsten20 and Goshen39 
recently. Amygdala is responsible for emotion and stress integration34,28, whose total dendritic 
length and spinogenesis of pyramidal and stellate but not bipolar cells increase after exposed to 
restraint stress for 10 to 20 days40. Fortified input may over-excites the amygdala, which receives 
glutamatergic projection from widespread cortical areas. In the view of neuron loss, pathologic 
changes in amygdala or solitary nucleus then emerge.  
Obesity. Obesity is very common all over the world. Although there are hypotheses about why 
obesity is related to type 2 diabetes and essential hypertension, the current explanations 
predominantly focus on the disorder of metabolism, but not that of central nervous system. In fact, 
many obese individuals have obstructive sleep apnoea syndrome41, although sometimes they 
didn’t aware. The hypoxia in sleep apnoea will cause a series of disorders, for example, activation 
of the sympathetic nervous system7. Evidence suggested that sleep apnoea is related to insulin 
resistance even in non-obese subjects7. Sleep apnoea is also related to disorders of cardiovascular 
system42. Furthermore, chronic sleep loss per se can alter the metabolic and endocrine functions43. 
Average sleep duration in 1960’s is 8 ~ 8.9 h, which decreases to 6.9 ~7.0 h at the end of the 20th 
century7. On the other hand, the high fatty acid intake of some obese individuals affects the health 
of neuron (see below). So, Sleep loss and energy excess, which is very common worldwide, are 
both related to insulin resistance. If the neurons at solitary nucleus or amygdala are impaired or 
lost, the cardiovascular system will be involved, so the chronic raising of blood pressure and 
insulin resistance can coexist with each other. It is sound to explain the relation between obesity 
and type 2 diabetes or essential hypertension by the viewpoint of neuron impairment or loss in 
brain. 
Taking food with high fatty acid. Evidence shows that the solitary nucleus represents the gate for 
central processing of vagally mediated afferent information related to fatty acid oxidation, and the 
central nucleus of the amygdala also plays a role in this mechanism44. If fatty acid is ingested, 
liver cell produced ketones will be released into circulation, and be utilized by nervous system as 
an energy source45. Food intake with high fatty acid leads to high levels of circulating ketones, so 
the probability of neuron injury in brain is increased. As discussed above, neurons at solitary 
nucleus or amygdala may be more vulnerable. 
Smoking. There are neurons at solitary nucleus that react to nicotine. The nicotinic and 
muscarinic actions can be detected in their membrane, both of which eliminate the reflex effect of 
pressure receptor at the aortic arch46. The nicotine in tobacco is distributed quickly through the 
bloodstream and crosses the blood-brain barrier into the central nervous system. The 
autoregulation function of neurons at solitary nucleus may be impaired by nicotine47, and the 
blood pressure cannot be accommodated promptly. The solitary nucleus is an important centre of 
the autonomic nervous system, and its impairment will further influence the metabolism. In 
addition, nicotine can activate the sympathetic nervous system48, and its metabolites49(for example, 
cotinine) can also have an activating role. Furthermore, Tobacco smoke contains monoamine 
oxidase inhibitors50, which significantly decrease MAO activity in smokers and delay the breaking 
down of monoaminergic neurotransmitters including adrenaline. So, smoking can be the risk 
factor for both type 2 diabetes and essential hypertension. 
Pregnancy. Some pregnant women have the symptoms resembling the type 2 diabetes, which 
named gestational diabetes51. It occurs in less than one tenth of all pregnancies and may disappear 


































health of the foetus or mother, but the pathogenesis is not clear. We should notice that women with 
gestational diabetes have a 17% ~ 63% risk of nongestational diabetes within 5 to 16 years after 
pregnancy51. This fact suggests that the neurons in brains of women at clinical risk may already be 
unhealthy, which are still competent reluctantly for their function. Changes on endocrine secretion 
during pregnancy may make the burden of these neurons heavier, and typical symptoms then 
manifest. If the neuron impairment exists at solitary nucleus, the hypertension in some pregnant 
women may share the same reason with gestational diabetes. Evidence showed that young adults 
with a very low birth weight have higher indexes of insulin resistance, glucose intolerance and 
higher blood pressure than those born at term52. This phenomenon suggests that the development 
which is not consummate may be a risk factor, and it is related to either the mother’s temporary 
condition or the genetic background proper. 
Aging and genetic background. The incidence of type 2 diabetes or essential hypertension 
increases with age. This age correlation also exists in Parkinson disease, Huntington disease and 
Alzheimer’s disease, which are related to neuron degeneration53. On one hand, diseases of this 
kind usually affect aged people because it is difficult for senescent neurons to recover from 
impairment. On the other hand, these diseases have a strong genetic background54,55,56. Not 
everybody will be affected during aging. The genetic characteristics portray the process of 
pathogenesis. The genetic background of type 2 diabetes and essential hypertension is one of the 
most attractive domains of current research, but the achievement is still far from clinical 
application. 
A special factor: lack of physical exercise. The sedentary lifestyle is a feature for whom work in 
an office. Type 2 diabetes and essential hypertension often affect these persons. Lack of physical 
exercise may be the reason. Plenty of evidence suggests that exercise can improve learning and 
memory57 and can counteract the mental decline that comes with age58. Exercise can also amend 
apnoea in sleep, regardless of body mass index, age or gender7. A recent review focused on the 
relation between exercise and neuronal health suggested that brain derived neurotrophic factor 
(BDNF) may be a candidate for the saviour59. Exercise augments the effects of BDNF on synaptic 
plasticity trough its tyrosine kinase B receptor59. This may be a crucial mechanism for neurons to 
recover from stress. If the BDNF is not sufficient, neurons in brain may be more vulnerable. 
BDNF is expressed by many neurons of the central nervous system, and can promote the 
regenerative sprouting60, so it can be regarded as a compensation for the bottleneck formed during 
neocortex expansion. 
 
Cognitive dysfunction in type 2 diabetes and essential hypertension 
Some patients with type 2 diabetes have cognitive impairment61. Type 2 diabetes now is 
implicated as a risk factor for age-related cognitive decline and dementia. Individuals with type 2 
diabetes also more likely to develop to Alzheimer’s disease or vascular dementia62. In the 
viewpoint of neuron loss, the projections originated from solitary nucleus or amygdale to 
widespread areas of neocortex is lost during the pathogenesis of type 2 diabetes. As a result, the 
autonomic feedback of neocortex and the emotional component of sensory input are weakened. 
The emotional component of cerebral function, which is related to attention, memory and 
judgment63 will be impaired. After typical clinical symptoms’ appearing, hyperglycaemia and 
some other metabolic disorders then make the condition worse. A phenomenon should be noticed 


































study on the effect of cognition in the oldest old (up to the age of 85) did not find an association 
between diabetes and cognitive decline23. Biessels mentioned that this may be a survivor effect23, 
and we agree with the point. The survivor effect can be explained by the genetic view.  
Essential hypertension is also related to dementia in older patients64. The pathogenesis of this 
kind of dementia, which is now not clear, may be similar to that of type 2 diabetes.  
 
Regarding the complications 
There are typical complications for type 2 diabetes and essential hypertension. Some of these 
complications, for example the disorders at kidney, retina and distal part of feet, may correlate to 
hyperglycaemia or disorders of microcirculation, which are explained well by traditional theories. 
Most of the complications generate after the neuron impairment or loss in brain, but in our opinion, 
the collapse of sexual functions65 and pain66 seen in some patients with type 2 diabetes may be 
related primarily to the pathogenesis of the disease. Unfortunately, based on the present reports of 
researches, the underlying mechanism still cannot be well elucidated. 
 
Significance, prospect and problems to solve 
According to the viewpoint of neuron impairment or loss, the pathogenesis of type 2 diabetes and 
essential hypertension can be now associated for a better prevention and cure. As expounding 
above, when diagnosed with either or both of these diseases, it is too late. The traditional 
treatments for type 2 diabetes focus on controlling of blood glucose, blood pressure and lipids to 
minimize the risk of long-term consequences, and those for essential hypertension aim at 
depressing the blood pressure. All these treatments do not catch the point, but postpone the 
aggravation of the symptoms. We suggest that prevention is far more effective and may be the 
exclusive way to cure both diseases. Modified lifestyle and neurotrophic medication may be the 
candidates for individuals with a definite genetic background. The valid prevention can protect 
neurons in brain, so the consequent symptoms will not emerge. If it is the case, millions of people 
will avoid the harassing of these two common chronic diseases, and resources of public health will 
not be wasted.  
 Although having a new light for the future research, there is still a distance from practice. 
First, the structure and function of human neocortex is far more complicated than that of some 
model animals. Therefore, there are difficulties in replicating chronic stress exactly. Technically, 
the complexity of surrounding structures of solitary nucleus and amygdala increases the difficulty 
for experimental analysis. So it is necessary to design experiments more carefully and rigorously 
in order to find the exact location and molecular mechanism of neuron impairment or loss. We 
have not approached the question that whether the over-activated inhibitory projection from 
amygdala per se is harmful to neurons at solitary nucleus, which is worthy of being deeply 
researched in future. The current focus of researches is on the hypothalamus67,15, but we don’t 
think this hypothalamus-centred view can well explain the pathogenesis of type 2 diabetes and 
essential hypertension. Second, because of the complexity of the anatomy and function of the 
brain, whether an individual is vulnerable to risk factors of theses two diseases may be decided by 
the postnatal developmental process. The process is regulated by more than one gene. This 
viewpoint is being confirmed by current researches9,11. That is to say, there is still a great deal of 
works to do for revealing the genetic regularities. Third, patients who have been diagnosed with 


































prevention. They have to be treated following the present guidelines in order to relieve the 
detriments from complications. It will be still an actual challenge to improve their quality of life.  
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Figure 1 | Process of the pathogenesis of type 2 diabetes and essential hypertension. Risk 
factors and the disease state are displayed in frames of ellipse, and the pathological changes are in 
the frames of rectangle. Neuron impairment or loss is the primary change of the whole process, 
and is responsible for the genesis of both type 2 diabetes and essential hypertension.  
 
Figure 2 | The schematic representation of the amygdala-solitary nucleus pathway. The 
amygdala belongs to the limbic system, which closely related to the neocortex. The solitary 
nucleus is one of the centres for the autonomic nervous system, and regulates the parasympathetic 
function. The amygdala-solitary nucleus pathway coordinates the psychical and visceral activities. 
The expansion and plastic changes of the neocortex may make the burden of the amygdala-solitary 
nucleus pathway too heavy.  
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